On November 9, 2012, he was a member of the Wujiang Science and Technology Township Youth League and Associate Professor Bai Xiaohui of Shanghai Jiaotong University. Professor of the title of “Shengyu” of Shanghai Jiaotong University, Associate Dean of School of Life Science and Technology, Shanghai Jiaotong University, Class A of the Central Organization Department "Thousand Talents Program" expert, director of Shengli Cell and Immunology Research Center, Ma Xiaojing, a tenured professor of Cornell University School of Medicine, went to Wuhu High-tech Zone to investigate and establish issues related to the "Thousand Talents Program" workstation and Suzhou Zhonglian Chemical Pharmaceutical Co., Ltd. Co., Ltd. conducted a docking negotiation.

According to the announcement of the Ministry of Environmental Protection of the “Interim Measures for the Environmental Protection Acceptance of Construction Project Completion” (National Environmental Regulation Environmental Impact [2017] No. 4), Article 11 (1): Environmental Protection for Construction Projects After the completion of the facility, the date of completion is disclosed.

Now our company's "Bio-pharmaceutical products production project (Phase II: Oral cephalosporin drugs)" has been completed and the environmental protection facilities have been completed. The date of completion is hereby announced.

Project Name: Suzhou Shengda Pharmaceutical Co., Ltd. produces biomedical products (second stage: oral cephalosporins)

Construction site: No. 6, Jinzi Road, Lili Town, Wujiang District, Suzhou City

Construction unit: Suzhou Shengda Pharmaceutical Co., Ltd.

Environmental Impact Assessment Agency: Suzhou Institute of Environmental Sciences

Completion date: November 5, 2019

Suzhou Shengda Pharmaceutical Co., Ltd.

Contact: Luo Gong

Contact number: 15862589268

Date of publicity: November 5, 2019

Address: No. 6, Jinzi Road, Lili Town, Wujiang District, Suzhou